- Home
- WST vs FWONA Comparison
WST vs FWONA Comparison
Compare WST & FWONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- FWONA
- Stock Information
- Founded
- WST 1923
- FWONA 1950
- Country
- WST United States
- FWONA United States
- Employees
- WST N/A
- FWONA N/A
- Industry
- WST Medical/Dental Instruments
- FWONA Broadcasting
- Sector
- WST Health Care
- FWONA Industrials
- Exchange
- WST Nasdaq
- FWONA Nasdaq
- Market Cap
- WST 23.2B
- FWONA 19.1B
- IPO Year
- WST N/A
- FWONA N/A
- Fundamental
- Price
- WST $333.19
- FWONA $85.99
- Analyst Decision
- WST Strong Buy
- FWONA Buy
- Analyst Count
- WST 5
- FWONA 2
- Target Price
- WST $437.75
- FWONA $77.00
- AVG Volume (30 Days)
- WST 482.3K
- FWONA 150.0K
- Earning Date
- WST 02-13-2025
- FWONA 11-07-2024
- Dividend Yield
- WST 0.25%
- FWONA N/A
- EPS Growth
- WST N/A
- FWONA N/A
- EPS
- WST 6.74
- FWONA 1.15
- Revenue
- WST $2,876,400,000.00
- FWONA $3,716,000,000.00
- Revenue This Year
- WST N/A
- FWONA $20.86
- Revenue Next Year
- WST $6.08
- FWONA $10.07
- P/E Ratio
- WST $49.37
- FWONA $84.03
- Revenue Growth
- WST N/A
- FWONA 35.32
- 52 Week Low
- WST $265.00
- FWONA $55.86
- 52 Week High
- WST $413.70
- FWONA $87.42
- Technical
- Relative Strength Index (RSI)
- WST 58.32
- FWONA 63.52
- Support Level
- WST $325.33
- FWONA $84.15
- Resistance Level
- WST $335.53
- FWONA $85.70
- Average True Range (ATR)
- WST 7.63
- FWONA 1.92
- MACD
- WST 0.36
- FWONA -0.19
- Stochastic Oscillator
- WST 76.56
- FWONA 71.57
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About FWONA Liberty Media Corporation Series A Liberty Formula One
Formula One Group controls the exclusive commercial and promotional rights to the FIA Formula One World Championship series, and the monetization of those rights is the primary business of the group. The firm is responsible for development and promotion of the Formula One race series in concert with its three partners: the FIA (the regulatory body), the teams that participate in the series, and the series' commercial partners, which include the race promoters, broadcasters, sponsors, and advertisers. The F1 schedule in 2023 will encompass 23 races held on five continents. Formula One Group is a subsidiary of Liberty Media, which purchased the firm in January 2017. Formula One stock is a tracking stock for the assets under Formula One Group with Liberty Media.